Why bypassing the digestive tract changes the game for melatonin research.
Rectal administration shows approximately 36% bioavailability compared to ~15% for standard oral melatonin. It reaches peak levels faster and avoids much of the first-pass liver metabolism.
* Rectal ~36% from a Karger cross-over PK study (IV, intravesical, rectal, transdermal, and vaginal routes; Pharmacokinetics and Safety…, 2020). Oral ~15% reflects the typical range in separate oral pharmacokinetic literature — figures from different studies, not one head-to-head trial.
Rectal delivery provides quicker onset and more direct systemic uptake. This makes it particularly interesting for research into higher or more efficient exposure protocols.
The rectal mucosa allows direct entry into systemic circulation via the inferior and middle rectal veins, largely avoiding hepatic first-pass effect that significantly reduces oral melatonin levels.
"Ever tried shouting through a closed door vs whispering right in someone's ear? That's basically the difference between swallowing melatonin and delivering it rectally."